Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have earned an average recommendation of “Hold” from the six analysts that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, two have given a hold recommendation and two have issued a buy recommendation on the company.
Several brokerages have recently weighed in on SAUHY. Barclays restated an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Citigroup restated a “sell” rating on shares of Straumann in a report on Thursday, April 23rd. Finally, Morgan Stanley restated an “underweight” rating on shares of Straumann in a report on Tuesday, April 14th.
Get Our Latest Report on SAUHY
Straumann Stock Performance
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Read More
- Five stocks we like better than Straumann
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
